Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.61 EUR | +1.95% | -2.25% | +8.75% |
04-05 | Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors | CI |
03-22 | Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition | MT |
Business Summary
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biodegradable Orthopedic Implants
100.0
%
| 3 | 100.0 % | 4 | 100.0 % | +32.78% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Rest of the World
62.3
%
| 2 | 59.2 % | 2 | 62.3 % | +39.69% |
United States
21.8
%
| 0 | 2.1 % | 1 | 21.8 % | +1,253.97% |
Europe
15.9
%
| 1 | 38.7 % | 1 | 15.9 % | -45.43% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Timo Lehtonen
CEO | Chief Executive Officer | 49 | 28/02/19 |
Director of Finance/CFO | 57 | 31/01/21 | |
Chairman | 53 | 30/04/16 | |
Esa Hallinen
COO | Chief Operating Officer | 57 | 06/08/23 |
Chief Tech/Sci/R&D Officer | 59 | 31/12/16 | |
Rami Ojala
SAM | Sales & Marketing | 49 | 31/12/21 |
Corporate Officer/Principal | 58 | 31/12/12 | |
General Counsel | 50 | 31/12/03 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 53 | 30/04/16 | |
Director/Board Member | 50 | 31/12/19 | |
Director/Board Member | 65 | 31/12/17 | |
Director/Board Member | 46 | 31/03/21 | |
Director/Board Member | 52 | 12/04/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 20,336,858 | 13,028,173 ( 64.06 %) | 0 | 64.06 % |
Company contact information
Sector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.75% | 57.18M | |
+73.37% | 12.39B | |
-17.09% | 8.08B | |
+16.88% | 7.25B | |
+3.57% | 5.86B | |
+11.77% | 5.35B | |
+29.65% | 4.63B | |
-17.74% | 4.19B | |
-35.26% | 2.44B | |
+3.09% | 2.07B |
- Stock Market
- Equities
- BRETEC Stock
- Company Bioretec Oy